Ib Jarle Christensen mainly focuses on Internal medicine, Pathology, Cancer, Gastroenterology and Colorectal cancer. The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine. His study in Pathology is interdisciplinary in nature, drawing from both Prognostic variable, Primary tumor, Surgical oncology, Ploidy and Tumor lysis syndrome.
His Cancer research is multidisciplinary, incorporating elements of Immunohistochemistry, Biomarker, Melanoma and Enzyme inhibitor. His Gastroenterology study integrates concerns from other disciplines, such as SuPAR, Metastasis, Univariate analysis, Blood plasma and Survival analysis. The various areas that he examines in his Colorectal cancer study include Carcinoembryonic antigen, Rectum, Blood transfusion, Immunology and Carcinoma.
His main research concerns Internal medicine, Oncology, Cancer, Colorectal cancer and Pathology. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Endocrinology. His Oncology research integrates issues from Chemotherapy, Ovarian cancer, Proportional hazards model, Breast cancer and Survival analysis.
His research in Cancer tackles topics such as Cancer research which are related to areas like Plasminogen activator. His Colorectal cancer research incorporates themes from Carcinoembryonic antigen, Prospective cohort study, Surgery, Immunology and Blood plasma. His work is dedicated to discovering how Pathology, Flow cytometry are connected with DNA and other disciplines.
His primary scientific interests are in Internal medicine, Oncology, Cancer, Colorectal cancer and Cancer research. His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology. His studies deal with areas such as Bioinformatics, Gene expression profiling, Ovarian cancer, Hazard ratio and Breast cancer as well as Oncology.
The Cancer study combines topics in areas such as Urokinase receptor and Biopsy, Pathology. His study in Colorectal cancer is interdisciplinary in nature, drawing from both Metastasis, Retrospective cohort study and Adenoma. His research in Cancer research intersects with topics in Methylation, Survival analysis, Immune system and DNA methylation.
The scientist’s investigation covers issues in Internal medicine, Oncology, Colorectal cancer, Cancer and Multivariate analysis. His research integrates issues of Gastroenterology and Immunology in his study of Internal medicine. His Oncology study also includes fields such as
His Colorectal cancer study integrates concerns from other disciplines, such as Logistic regression, microRNA and Metastasis. His biological study spans a wide range of topics, including Urokinase receptor and Observational study, Prospective cohort study, Pathology. His Multivariate analysis research includes themes of Stage, Gynecology, Cohort study and Population study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis†
Lars L. Vindeløv;Ib J. Christensen;Nis I. Nissen.
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.
Maxime P. Look;Wim L. J. van Putten;Michael J. Duffy;Nadia Harbeck.
Journal of the National Cancer Institute (2002)
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
Merete Lund Hetland;Ib Jarle Christensen;Ulrik Tarp;Lene Dreyer.
Arthritis & Rheumatism (2010)
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.
Jan Grøndahl-Hansen;Ib Jarle Christensen;Christian Rosenquist;Nils Brünner.
Cancer Research (1993)
Standardization of high‐resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards
Lars L. Vindeløv;Ib J. Christensen;Nis I. Nissen.
Duodenal adenomatosis in familial adenomatous polyposis
S Bülow;J Björk;I J Christensen;O Fausa.
Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis
Ross W. Stephens;Hans Jørgen Nielsen;Ib J. Christensen;Ole Thorlacius-Ussing.
Journal of the National Cancer Institute (1999)
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
H H Schmidt;L. Bastholt;P Geertsen;I J Christensen.
British Journal of Cancer (2005)
Association between High Concentrations of Mr 52,000 Cathepsin D and Poor Prognosis in Primary Human Breast Cancer
Susan M. Thorpe;Henri Rochefort;Marcel Garcia;Gilles Freiss.
Cancer Research (1989)
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
Boye Schnack Nielsen;Stine Jørgensen;Jacob Ulrik Fog;Rolf Søkilde.
Clinical & Experimental Metastasis (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: